By Dr Brendan Patrick Jacka

Journal articles

Goodman-Meza D; Martinello M; Masters J; Russell D; Jacka B; Matthews GV; Dore GJ, 2026, 'Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian Hospital', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70169

Shaw LC; Park CJ; Scott JA; Figgatt MC; Goldman JE; Jacka B; Marshall BDL; Badea A; Macmadu A, 2026, 'Documenting the Emergence of Xylazine Among People Who Use Drugs in Rhode Island: An Analysis of Dried Blood Apot Samples', Substance Use and Addiction Journal, http://dx.doi.org/10.1177/29767342261450958

Masters J; Goodman-Meza D; Russell D; Marks L; McCreary E; Jacka B; Seear K; Davis JS; Matthews G; Martinello M; Tong SYC; Dore GJ, 2025, 'Bacterial and fungal infections in persons who inject drugs', Clinical Microbiology Reviews, 38, http://dx.doi.org/10.1128/cmr.00162-23

Watson RJ; McCauley PS; Taylor A; Morgan E; Jacka B; Eaton LA, 2025, 'Aging Concerns Related to Sexuality and Gender: HIV Prevention and Healthy Aging', AIDS and Behavior, 29, pp. 1569 - 1579, http://dx.doi.org/10.1007/s10461-025-04627-9

Masters J; Jacka B; Barault M; Goodman-Meza D; Russell D; Matthews GV; Dore GJ; Valerio H; Martinello M, 2025, 'Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study', Open Forum Infectious Diseases, 12, pp. ofaf257, http://dx.doi.org/10.1093/ofid/ofaf257

Jacka BP; Cheng QL; Schiavone B; Darley DR; Kelleher AD; Dore GJ; Matthews GV, 2025, 'Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era', Open Forum Infectious Diseases, 12, pp. ofaf142, http://dx.doi.org/10.1093/ofid/ofaf142

Weiss NH; Forkus SR; Raudales AM; Kiefer R; Thomas ED; Goldstein SC; Lin N; Samuels EA; Marshall BDL; Jacka BP, 2024, 'Emotion Dysregulation as a Risk Factor for Posttraumatic Stress Disorder Stemming from Opioid Overdose Responding Among Community Laypeople', International Journal of Mental Health and Addiction, 22, pp. 3510 - 3519, http://dx.doi.org/10.1007/s11469-023-01063-5

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, pp. 3315, http://dx.doi.org/10.1038/s41467-024-47720-8

Harvey L; Jacka B; Bazerman L; Thomas A; Moody M; Irvin R; Beckwith CG, 2024, 'Feasibility and Performance of a Point-of-Care Hepatitis C RNA Assay in a Community Supervision Cohort', JAMA Network Open, 7, pp. e2438222, http://dx.doi.org/10.1001/jamanetworkopen.2024.38222

Jacka BP; Lin N; Kiefer R; Forkus SR; Raudales AM; Thomas ED; Samuels EA; Marshall BDL; Weiss NH, 2024, 'Risk and Protective Factors Associated With Posttraumatic Stress Disorder Among Layperson Responders to Opioid Overdose Incidents', Psychological Trauma Theory Research Practice and Policy, 17, pp. 207 - 215, http://dx.doi.org/10.1037/tra0001781

Nolen S; Wilson T; Jacka BP; Li Y; Beaudoin FL; Marshall BDL, 2023, 'Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose', Addictive Behaviors Reports, 17, http://dx.doi.org/10.1016/j.abrep.2023.100496

Wunsch C; Wightman R; Pratty C; Jacka B; Hallowell BD; Clark S; Davis CS; Samuels EA, 2023, 'Thirty-day Treatment Continuation After Audio-only Buprenorphine Telehealth Initiation', Journal of Addiction Medicine, 17, pp. 206 - 209, http://dx.doi.org/10.1097/ADM.0000000000001077

Ranney M; Marshall BDL; Langdon K; Wiehe S; Aalsma M; Jacka B; Peachey A; Beaudoin F, 2023, 'Increasing Peer Support for Opioid Use Disorder Recovery During COVID-19 Through Digital Health: Protocol for a National Randomized Controlled Trial', Iproceedings, 9, pp. e39424, http://dx.doi.org/10.2196/39424

Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL, 2022, 'Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study', Journal of Acquired Immune Deficiency Syndromes, 91, pp. 449 - 452, http://dx.doi.org/10.1097/QAI.0000000000003093

Macmadu A; Yolken A; Frueh L; Toussaint JR; Newman R; Jacka BP; Collins AB; Marshall BDL, 2022, 'Characteristics of events in which police responded to overdoses: an examination of incident reports in Rhode Island', Harm Reduction Journal, 19, pp. 116, http://dx.doi.org/10.1186/s12954-022-00698-2

Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL, 2022, 'Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose A Randomized Clinical Trial', JAMA Network Open, 5, pp. e2225582, http://dx.doi.org/10.1001/jamanetworkopen.2022.25582

Jacka BP; Bazerman LB; Dickerson C; Moody M; Martin J; Patry E; Cady T; Compere H; Boudreau M; Beckwith CG, 2022, 'Feasibility of hepatitis C virus testing and linkage in community supervision offices: Great potential but persistent challenges', International Journal of Drug Policy, 103, pp. 103668, http://dx.doi.org/10.1016/j.drugpo.2022.103668

, 2022, 'Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program', Academic Emergency Medicine, 29, pp. 294 - 307, http://dx.doi.org/10.1111/acem.14409

Min S; Shin J; Jacka B; Bazerman L; Nijhawan AE; Beckwith C, 2021, '841. Survey of Current HIV and HCV Policies and Practices in Prisons and Jails Serving High-Risk Geographic Hotspots', Open Forum Infectious Diseases, 8, pp. 511 - 512, http://dx.doi.org/10.1093/ofid/ofab466.1037

, 2021, 'Race, ethnicity, and emergency department post-overdose care', Journal of Substance Abuse Treatment, 131, http://dx.doi.org/10.1016/j.jsat.2021.108588

, 2021, 'Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation', American Journal of Emergency Medicine, 50, pp. 409 - 412, http://dx.doi.org/10.1016/j.ajem.2021.08.071

Jacka BP; Janssen T; Garner BR; Yermash J; Yap KR; Ball EL; Hartzler B; Becker SJ, 2021, 'Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder', Drug and Alcohol Dependence, 221, pp. 108617, http://dx.doi.org/10.1016/j.drugalcdep.2021.108617

Høj SB; Jacka B; Minoyan N; Bussière P; Bruneau J, 2021, 'Deconstructing the ‘cheque effect’: short-term changes in injection drug use after receiving income assistance and associated factors', Addiction, 116, pp. 571 - 582, http://dx.doi.org/10.1111/add.15192

Singleton AL; Marshall BDL; Bessey S; Harrison MT; Galvani AP; Yedinak JL; Jacka BP; Goodreau SM; Goedel WC, 2021, 'Network structure and rapid HIV transmission among people who inject drugs: A simulation-based analysis', Epidemics, 34, http://dx.doi.org/10.1016/j.epidem.2020.100426

Jacka B; Beaudoin F; Li Y; Nimaja E; Yedinak J; Samuels E; Marshall BDL, 2021, 'Objective Outcome Measures in Randomized Clinical Trials of Interventions to Reduce Risk of Opioid Overdose Following Discharge From the Emergency Department: Utility of Administrative Data Linkage', Journal of Addiction Medicine, 15, pp. 174 - 175, http://dx.doi.org/10.1097/ADM.0000000000000705

Cho D; Jacka B; Marshall B; Beaudoin F, 2021, '239 Evaluating the Role of Recovery Capital on Willingness to Enter Treatment for Emergency Department Patients With Opioid Use Disorders', Annals of Emergency Medicine, 78, pp. s97, http://dx.doi.org/10.1016/j.annemergmed.2021.09.251

Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL, 2020, 'A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial', Trials, 21, pp. 976, http://dx.doi.org/10.1186/s13063-020-04898-8

Gaur DS; Jacka BP; Green TC; Samuels EA; Hadland SE; Krieger MS; Yedinak JL; Marshall BDL, 2020, 'US drug overdose mortality: 2009–2018 increases affect young people who use drugs', International Journal of Drug Policy, 85, http://dx.doi.org/10.1016/j.drugpo.2020.102906

Jacka BP; Phipps E; Marshall BDL, 2020, 'Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs', International Journal of Drug Policy, 83, http://dx.doi.org/10.1016/j.drugpo.2020.102895

Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J, 2020, 'Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs', AIDS and Behavior, 24, pp. 2400 - 2408, http://dx.doi.org/10.1007/s10461-020-02800-w

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Applegate T; Hajarizadeh B; Ezard N; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954

Jacka B; Larney S; Degenhardt L; Janjua N; Høj S; Krajden M; Grebely J; Bruneau J, 2020, 'Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada', American Journal of Public Health, 110, pp. 45 - 50, http://dx.doi.org/10.2105/AJPH.2019.305379

Catlett B; Lamoury FMJ; Bajis S; Hajarizadeh B; Martinez D; Mowat Y; Cunningham PH; Jacka BP; Cloherty GA; Marks P; Dore GJ; Grebely J; Applegate TL, 2019, 'Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study', Journal of Viral Hepatitis, 26, pp. 1423 - 1430, http://dx.doi.org/10.1111/jvh.13196

Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J, 2019, 'Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada', Journal of Viral Hepatitis, 26, pp. 1413 - 1422, http://dx.doi.org/10.1111/jvh.13194

Høj SB; Jacka B; Minoyan N; Artenie AA; Bruneau J, 2019, 'Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs', International Journal of Drug Policy, 72, pp. 11 - 23, http://dx.doi.org/10.1016/j.drugpo.2019.04.001

Makarenko I; Artenie A; Hoj S; Minoyan N; Jacka B; Zang G; Barlett G; Jutras-Aswad D; Martel-Laferriere V; Bruneau J, 2019, 'Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?', International Journal of Drug Policy, 72, pp. 69 - 76, http://dx.doi.org/10.1016/j.drugpo.2019.04.002

Artenie AA; Minoyan N; Jacka B; Høj S; Jutras-Aswad D; Roy É; Gauvin L; Zang G; Bruneau J, 2019, 'Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs', CMAJ, 191, pp. E462 - E468, http://dx.doi.org/10.1503/cmaj.181506

Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222

Jacka B; Kemp R; Degenhardt L; Peacock A; Clare P; Bruno R; Dev A; Sotade O; Larance B, 2019, 'Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007–2015', Drug and Alcohol Review, 38, pp. 159 - 168, http://dx.doi.org/10.1111/dar.12908

Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B, 2018, 'Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users', Drug and Alcohol Review, 37, pp. 664 - 670, http://dx.doi.org/10.1111/dar.12688

Jacka B; Bray BC; Applegate TL; Marshall BDL; Lima VD; Hayashi K; DeBeck K; Raghwani J; Harrigan PR; Krajden M; Montaner JSG; Grebely J, 2018, 'Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach', Journal of Viral Hepatitis, 25, pp. 28 - 36, http://dx.doi.org/10.1111/jvh.12758

Jacka B; Peacock A; Degenhardt L; Bruno R; Clare P; Kemp R; Dev A; Larance B, 2017, 'Trends in PIEDs use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015', International Journal of Drug Policy, 46, pp. 74 - 78, http://dx.doi.org/10.1016/j.drugpo.2017.05.048

Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky JM; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review', Hepatology Communications, 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050

Bartlett SR; Applegate T; Jacka B; Lamoury F; Bull R; Danta M; Bradshaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2017, 'P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015', Journal of Virus Eradication, 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30747-0

Montoya V; Olmstead A; Tang P; Cook D; Janjua N; Grebely J; Jacka B; Poon AFY; Krajden M, 2016, 'Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing', Infection Genetics and Evolution, 43, pp. 329 - 337, http://dx.doi.org/10.1016/j.meegid.2016.06.015

Bradshaw D; Raghwani J; Jacka B; Sacks-Davis R; Lamoury F; Down I; Prestage G; Applegate TL; Hellard M; Sasadeusz J; Dore GJ; Pybus OG; Matthews GV; Danta M, 2016, 'Venue-based networks may underpin HCV transmissions amongst HIV-infected gay and bisexual men', Plos One, 11, pp. e0162002, http://dx.doi.org/10.1371/journal.pone.0162002

Jacka B; Applegate T; Poon AF; Raghwani J; Harrigan PR; Debeck K; Milloy MJ; Krajden M; Olmstead A; Joy JB; Marshall BDL; Hayashi K; Pybus OG; Lima VD; Magiorkinis G; Montaner J; Lamoury F; Dore GJ; Wood E; Grebely J, 2016, 'Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada', Journal of Hepatology, 64, pp. 1247 - 1255, http://dx.doi.org/10.1016/j.jhep.2016.02.031

Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection Genetics and Evolution, 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028

Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', Plos One, 10, pp. e0131437, http://dx.doi.org/10.1371/journal.pone.0131437

Back to profile page